Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies

Neurology

Volumn 50, Issue 3, 1998, Pages 652-657

  Lucchinetti, Claudia F ^a   Kimmel, David W ^a   Lennon, Vanda A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER;

ADULT; ARTICLE; AUTOIMMUNITY; BREAST CARCINOMA; BRONCHOSCOPY; CEREBELLAR ATAXIA; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LUNG SMALL CELL CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MELANOMA; MYOPATHY; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROSTATE CARCINOMA; SPINAL CORD DISEASE; THORACOTOMY; THORAX RADIOGRAPHY;

EID: 0031897529     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.3.652     Document Type: Article

References (40)

1. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer: antineuronal antibody that also reacts with the tumor. Am J Med 1986;80:45-52.
2. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 1988;38:1391-1398.
3. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine 1992;71: 59-72.
4. Kimmel DW, O'Neill BP, Lennon VA. Subacute sensory neuronopathy associated with small cell lung carcinoma: diagnosis aided by autoimmune serology. Mayo Clin Proc 1988;63: 29-32.
5. Lennon VA, Sas DF, Busk MF, et al. Enteric neuronal autoantibodies in pseudo-obstruction with small-cell lung carcinoma. Gastroenterology 1991;100:137-142.
6. Lennon VA, Camilleri M, Miller LJ. Enteric neuronal autoantibodies in pseudoobstruction with small cell lung carcinoma. Gastroenterology 1991;101:1143-1144. Letter.
7. Lennon VA. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology 1994;44: 2412-2415.
8. Henson RA, Urich H. Cancer and the nervous system: the neurological manifestations of systemic malignant disease. Oxford, UK: Blackwell, 1982.
9. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985;35:538-543.
10. Lennon VA. Anti-Purkinje cell cytoplasmic and neuronal nuclear antibodies aid diagnosis of paraneoplastic autoimmune neurological disorders. J Neurol Neurosurg Psychiatry 1989; 52:1438-1439. Letter.
11. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer: a quantitative Western blot analysis. Ann Neurol 1990;27:544-552.
12. Szabo A, Dalmau J, Manley G, et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 1991;67:325-333.
13. Jean WC, Dalmau J, Ho A, Posner JB. Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 1994;44:140-147.
14. Altermatt HJ, Rodriguez M, Scheithauer BW, Lennon VA. Paraneoplastic anti-Purkinje and type-I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral and autonomic nervous system cells. Lab Invest 1991;65:412-420.
15. Manley GT, Smitt PS, Dalmau J, Posner JB. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol 1995;38:102-110.
16. King PH, Dropcho EJ. Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma. Ann Neurol 1996;39:679-681.
17. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991;41: 1757-1764.
18. Kiers L, Altermatt HJ, Lennon VA. Paraneoplastic antineuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma. Mayo Clin Proc 1991;66:1209-1216.
19. Malinow K, Yannakakis GD, Glusman SM, et al. Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome. Ann Neurol 1986;20:535-537.
20. Schaumburg H, Kaplan J, Windebank AJ, et al. Sensory neuronopathy from pyridoxine abuse: a new mega vitamin syndrome. N Engl J Med 1983;309:445-448.
21. Daniel SE, Love S, Scaravilli F, Harding AE. Encephalomyelo-neuropathy in the absence of a detectable neoplasm: clinical and postmortem findings in three cases. Acta Neuropathol (Berl) 1985;66:311-317.
22. Anton-Culver H, Culver BD, Kurosaki T, Osam KE, Lee JB. Incidence of lung cancer by histological type from a population-based registry. Cancer Res 1988;48:6580-6583.
23. Kennelly KD, Dodick DW, Pascuzzi RM, Albain KS, Lennon VA. Neuronal autoantibodies and paraneoplastic neurological syndromes associated with extrapulmonary small cell carcinoma. Neurology 1997;48:A31. Abstract.
24. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB. The expression of the Hu (paraneoplastic encephalomyelitis/ sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 1992;141:881-886.
25. Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium channel-ω-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc 1989;64:1498-1504.
26. Zbar B, Brauch H, Talmadge C, Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 1987;327:721-724.
27. Gulya AJ. Neurologic paraneoplastic syndromes with neurologic manifestations. Laryngoscope 1993;103:754-761.
28. McGill T. Carcinomatous encephalomyelitis with auditory and vestibular manifestations. Ann Otol Rhinol Laryngol 1976;85: 120-126.
29. Heidenreich F, Schober R, Brinck U, Hartung H-P. Multiple paraneoplastic syndromes in a patient with antibodies to neuronal nucleoproteins (anti-Hu). J Neurol 1995;242:210-216.
30. Miller NR. Paraneoplastic syndromes. In: Miller NR, ed. Walsh and Hoyt's clinical neuro-ophthalmology. 4th ed. Baltimore: Williams & Wilkins, 1988:1710-1746.
31. Ahmed MN, Carpenter S. Autonomic neuropathy and carcinoma of the lung. Can Med Assoc J 1975;113:410-412.
32. Lhermitte F, Gray F, Lyon-Caen O, Pertuiset BF, Bernard P. Paralysis of digestive tract with lesions of myenteric plexuses: a new paraneoplastic syndrome. Rev Neurol (Paris) 1980;136: 825-836.
33. Schuffler MD, Baird HW, Fleming CR, et al. Intestinal pseudo-obstruction as the presenting manifestation of small cell carcinoma of the lung: a paraneoplastic neuropathy of the gastrointestinal tract. Ann Intern Med 1983;98:129-134.
34. Chinn JS, Schuffler MD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988;95:1279-1286.
35. Condom E, Vidal A, Rota R, Graus F, Dalmau J, Ferrer I. Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu autoantibodies. Virchows Archiv A, Pathol Anat Histopathol 1993;423:507-511.
36. Moll JW, Henzen-Logmans SC, Van der Meche FG, Vecht CH. Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry 1993;56:112. Letter.
37. Counsell CE, McLeod M, Grant R. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin. Neurology 1994;44:1184-1185.
38. Graus F, Vega F, Delattre JY, et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal antibodies. Neurology 1992;42:536-540.
39. Lennon VA. Calcium channel and related paraneoplastic disease autoantibodies. In: Peter JB, Shoenfeld Y, eds. Autoantibodies. The Netherlands: Elsevier Science B.V., 1996:139-147.
40. Vernino S, Adamski J, Lennon VA. Neuronal nicotinic acetylcholine receptor autoantibodies in patients with subacute autonomic neuropathy, Isaacs' syndrome, or small cell carcinoma-related paraneoplastic disorders. Neurology 1998; in press. Abstract.